Skip to main content
Erschienen in: Journal of Natural Medicines 3/2018

21.04.2018 | Original Paper

Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway

verfasst von: Yuanbang Lin, Mingwei Sheng, Yijie Ding, Nan Zhang, Yayue Song, Hongyin Du, Ning Lu, Wenli Yu

Erschienen in: Journal of Natural Medicines | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Berberine (BBR) has been demonstrated to protect against renal ischemia/reperfusion injury; however, the underlying molecular mechanism is largely unknown. In the present study, we examined the role of silent information regulator 1 (Sirt1)/p53 in the protective effect of BBR on hypoxia/reoxygenation (H/R)-mediated mitochondrial dysfunction in rat renal tubular epithelial cells (NRK-52E cells). NRK-52E cells were preconditioned with small interfering RNA targeting Sirt1 (Sirt1-siRNA) and BBR before subjected to H/R. Cell damage was assessed by CCK8 assay and detection of oxidative parameters. The apoptotic rate was determined by flow cytometry and Hoechst 33258 staining. The expression of apoptotic markers, Sirt1, p53 and the translocation of p53 were examined by Western blotting assay. Nuclear p53 deacetylation by Sirt1 was detected using immunoprecipitation. Compared with the H/R group, BBR pretreatment increased cell viability and inhibited mitochondrial oxidative stress and apoptosis. Protein expression of Sirt1 was also enhanced along with a reduction of p53. Furthermore, both nuclear translocation of p53 and its acetylation were inhibited in NRK-52E cells pretreated with BBR. However, the knockdown of Sirt1 counteracted the renoprotection of BBR. BBR preconditioning protects rat renal tubular epithelial cells against H/R-induced mitochondrial dysfunction via regulating the Sirt1/p53 pathway.
Literatur
1.
Zurück zum Zitat Ponticelli C (2014) Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant 29:1134–1140CrossRef Ponticelli C (2014) Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant 29:1134–1140CrossRef
2.
Zurück zum Zitat Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment. World J Transplant 5:52–67CrossRef Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment. World J Transplant 5:52–67CrossRef
3.
Zurück zum Zitat Kezic A, Spasojevic I, Lezaic V, Bajcetic M (2016) Mitochondria-targeted antioxidants: future perspectives in kidney ischemia reperfusion injury. Oxid Med Cell Longev 2016:2950503CrossRef Kezic A, Spasojevic I, Lezaic V, Bajcetic M (2016) Mitochondria-targeted antioxidants: future perspectives in kidney ischemia reperfusion injury. Oxid Med Cell Longev 2016:2950503CrossRef
4.
Zurück zum Zitat Chatauret N, Badet L, Barrou B, Hauet T (2014) Ischemia-reperfusion: from cell biology to acute kidney injury. Prog Urol 1:S4–S12CrossRef Chatauret N, Badet L, Barrou B, Hauet T (2014) Ischemia-reperfusion: from cell biology to acute kidney injury. Prog Urol 1:S4–S12CrossRef
5.
Zurück zum Zitat Guan Y, Hao CM (2016) SIRT1 and kidney function. Kidney Dis (Basel) 1:258–265CrossRef Guan Y, Hao CM (2016) SIRT1 and kidney function. Kidney Dis (Basel) 1:258–265CrossRef
6.
Zurück zum Zitat Kumar A, Chauhan S (2016) How much successful are the medicinal chemists in modulation of SIRT1: a critical review. Eur J Med Chem 119:45–69CrossRef Kumar A, Chauhan S (2016) How much successful are the medicinal chemists in modulation of SIRT1: a critical review. Eur J Med Chem 119:45–69CrossRef
7.
Zurück zum Zitat Van Leeuwen I, Lain S (2009) Sirtuins and p53. Adv Cancer Res 102:171–195CrossRef Van Leeuwen I, Lain S (2009) Sirtuins and p53. Adv Cancer Res 102:171–195CrossRef
8.
Zurück zum Zitat Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Araujo JA, Kupiec-Weglinski JW (2017) Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia- reperfusion injury. J Hepatol 67:1232–1242CrossRef Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Araujo JA, Kupiec-Weglinski JW (2017) Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia- reperfusion injury. J Hepatol 67:1232–1242CrossRef
9.
Zurück zum Zitat Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122:2170–2182CrossRef Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122:2170–2182CrossRef
10.
Zurück zum Zitat He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM (2010) Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120:1056–1068CrossRef He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM (2010) Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120:1056–1068CrossRef
11.
Zurück zum Zitat Ying Y, Kim J, Westphal SN, Long KE, Padanilam BJ (2014) Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J Am Soc Nephrol 25:2707–2716CrossRef Ying Y, Kim J, Westphal SN, Long KE, Padanilam BJ (2014) Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J Am Soc Nephrol 25:2707–2716CrossRef
12.
Zurück zum Zitat Cicero AF, Baggioni A (2016) Berberine and its role in chronic disease. Adv Exp Med Biol 928:27–45CrossRef Cicero AF, Baggioni A (2016) Berberine and its role in chronic disease. Adv Exp Med Biol 928:27–45CrossRef
13.
Zurück zum Zitat Jin Y, Khadka DB, Cho WJ (2016) Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat 26:229–243CrossRef Jin Y, Khadka DB, Cho WJ (2016) Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat 26:229–243CrossRef
14.
Zurück zum Zitat Kumar A, Ekavali, Chopra K, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288–297CrossRef Kumar A, Ekavali, Chopra K, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288–297CrossRef
15.
Zurück zum Zitat Lin Y, Sheng M, Weng Y, Xu R, Lu N, Du H, Yu W (2017) Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy. Biochem Biophys Res Commun 483:885–891CrossRef Lin Y, Sheng M, Weng Y, Xu R, Lu N, Du H, Yu W (2017) Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy. Biochem Biophys Res Commun 483:885–891CrossRef
16.
Zurück zum Zitat Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, Shi L, Ren H, Du H (2013) Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med 11(1):24CrossRef Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, Shi L, Ren H, Du H (2013) Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med 11(1):24CrossRef
17.
Zurück zum Zitat Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG, Sinclair DA, Palmeira CM, Rolo AP (1822) Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta 2012:185–195 Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG, Sinclair DA, Palmeira CM, Rolo AP (1822) Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta 2012:185–195
18.
Zurück zum Zitat Zhang H, Shan Y, Wu Y, Xu C, Yu X, Zhao J, Yan J, Shang W (2017) Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells. Int Immunopharmacol 52:93–100CrossRef Zhang H, Shan Y, Wu Y, Xu C, Yu X, Zhao J, Yan J, Shang W (2017) Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells. Int Immunopharmacol 52:93–100CrossRef
19.
Zurück zum Zitat Laptenko O, Prives C (2017) P53: master of life, death, and the epigenome. Genes Dev 31:955–956CrossRef Laptenko O, Prives C (2017) P53: master of life, death, and the epigenome. Genes Dev 31:955–956CrossRef
20.
Zurück zum Zitat Gu B, Zhu WG (2012) Surf the post-translational modification network of p53 regulation. Int J Biol Sci 8:672–684CrossRef Gu B, Zhu WG (2012) Surf the post-translational modification network of p53 regulation. Int J Biol Sci 8:672–684CrossRef
21.
Zurück zum Zitat Reed SM, Quelle DE (2014) p53 acetylation: regulation and consequences. Cancers (Basel) 7:30–69CrossRef Reed SM, Quelle DE (2014) p53 acetylation: regulation and consequences. Cancers (Basel) 7:30–69CrossRef
22.
Zurück zum Zitat Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W (2011) SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301:F427–F435CrossRef Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W (2011) SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301:F427–F435CrossRef
23.
Zurück zum Zitat Hao J, Wei Q, Mei S, Li L, Su Y, Mei C, Dong Z (2017) Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. Kidney Int 91:106–118CrossRef Hao J, Wei Q, Mei S, Li L, Su Y, Mei C, Dong Z (2017) Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. Kidney Int 91:106–118CrossRef
24.
Zurück zum Zitat Park GB, Park SH, Kim D, Kim YS, Yoon SH, Hur DY (2016) Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α. Int J Oncol 49:411–421CrossRef Park GB, Park SH, Kim D, Kim YS, Yoon SH, Hur DY (2016) Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α. Int J Oncol 49:411–421CrossRef
25.
Zurück zum Zitat Wang N, Zhu M, Wang X, Tan HY, Tsao SW, Feng Y (1839) Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim Biophys Acta 2014:849–857 Wang N, Zhu M, Wang X, Tan HY, Tsao SW, Feng Y (1839) Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim Biophys Acta 2014:849–857
26.
Zurück zum Zitat Qin W, Xie W, Yang X, Xia N, Yang K (2016) Inhibiting microRNA-449 attenuates cisplatin-induced injury in NRK-52E cells possibly via regulating the SIRT1/P53/BAX pathway. Med Sci Monit 22:818–823CrossRef Qin W, Xie W, Yang X, Xia N, Yang K (2016) Inhibiting microRNA-449 attenuates cisplatin-induced injury in NRK-52E cells possibly via regulating the SIRT1/P53/BAX pathway. Med Sci Monit 22:818–823CrossRef
27.
Zurück zum Zitat Gao R, Chen J, Hu Y, Li Z, Wang S, Shetty S, Fu J (2014) Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury. PLoS One 9:e98909CrossRef Gao R, Chen J, Hu Y, Li Z, Wang S, Shetty S, Fu J (2014) Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury. PLoS One 9:e98909CrossRef
28.
Zurück zum Zitat Yu J, Zhang L (2003) No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4:248–249CrossRef Yu J, Zhang L (2003) No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4:248–249CrossRef
29.
Zurück zum Zitat Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25:4056–4066CrossRef Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25:4056–4066CrossRef
30.
Zurück zum Zitat Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330:1390–1393CrossRef Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330:1390–1393CrossRef
31.
Zurück zum Zitat Zhang J, Huang K, O’Neill KL, Pang X, Luo X (2016) Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis 7:e2266CrossRef Zhang J, Huang K, O’Neill KL, Pang X, Luo X (2016) Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis 7:e2266CrossRef
32.
Zurück zum Zitat Zeng XH, Zeng XJ, Li YY (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173–176CrossRef Zeng XH, Zeng XJ, Li YY (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173–176CrossRef
Metadaten
Titel
Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway
verfasst von
Yuanbang Lin
Mingwei Sheng
Yijie Ding
Nan Zhang
Yayue Song
Hongyin Du
Ning Lu
Wenli Yu
Publikationsdatum
21.04.2018
Verlag
Springer Singapore
Erschienen in
Journal of Natural Medicines / Ausgabe 3/2018
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-018-1210-1

Weitere Artikel der Ausgabe 3/2018

Journal of Natural Medicines 3/2018 Zur Ausgabe